
Chris Klomp, Deputy CMS Administrator and Medicare Director, highlights President Trump's efforts to lower medication costs for Americans, including implementing 'most favored nation' drug pricing which has significantly reduced prices for drugs like GLP-1 and fertility medicines. He also emphasizes historical actions on price transparency, explaining that informed consumers empower competition and lead to better quality and lower prices in healthcare.